Results 251 to 260 of about 166,368 (358)

Allogeneic stem cell transplantation from variant-carrying family donors leads to long-term engraftment in Telomere Biology Disorders. [PDF]

Blood Cancer J
Güzel N, Schumacher Y, Kricheldorf K, Vieri M, Kirschner M, Gerhard-le Gars AC, Panse J, Tometten M, Walter J, Gehrig A, Kunstmann E, Holthöfer L, Schweiger S, Wolff D, Kraft F, Elbracht M, Kurth I, Brümmendorf TH, Meyer R, Beier F.   +19 more
europepmc   +1 more source

Phagocytic Mesothelial Cells in Pericardial Effusion Following Allogeneic Peripheral Blood Stem Cell Transplantation for Chronic Active Epstein–Barr Virus Infection: A Distinctive Cytomorphological and Immunocytochemical Case Study

Diagnostic Cytopathology, EarlyView.
ABSTRACT Phagocytic activity of mesothelial cells is a rare phenomenon requiring careful differentiation from histiocytic hemophagocytosis to ensure appropriate patient management, as these phenomena could exhibit distinct clinical implications. In this study, we report a case of phagocytic mesothelial cells found in pericardial effusion that developed
Hidetoshi Satomi, Ayumi Ryu, Sei Murayama, Hiroya Kojima, Satoshi Tanada, Keiichiro Honma   +5 more
wiley   +1 more source

A Comparison of Radiation and Alkylator-Based Conditioning Therapy Regimens for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Clinician's Perspective. [PDF]

Curr Oncol
Marinos Velarde A, Alvarenga Thiebaud J, Madanat Y, Toor A.   +3 more
europepmc   +1 more source

Advanced extracellular vesicle immunotherapy

FlexMat, EarlyView.
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang, Yunfei Mu, Xianyue Ji, Xiaoting Jiang, Ruiheng Wang, Xianguang Ding, Lianhui Wang   +6 more
wiley   +1 more source

It takes two to tango: allogeneic stem cell transplantation and <i>FLT3</i> tyrosine kinase inhibitor therapy. [PDF]

Haematologica
Cornelissen JJ, Versluis J.
europepmc   +1 more source

In Vivo T Cell Depletion With Dexamethasone Reduces Graft Versus Host Disease (GVHD) With Minimal Side Effects and No Additional Risk of Early Relapse After Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

, 2011
Raquel Innis‐Shelton, Khairil Ashraff, Y. Li, Nalini Mehta, Donna Salzman, Arabella B. Tilden, William P. Vaughan, Lawrence S. Lamb   +7 more
openalex   +1 more source

Guideline for the In Vivo Immunomodulatory Activity Test of Polysaccharide Based on Cyclophosphamide‐Induced Mouse Model

Food Safety and Health, EarlyView.
Abstract graph of the in vivo immunomodulatory activity of polysaccharide based on a cyclophosphamide‐induced mouse model. ABSTRACT The immune system serves as the primary defense mechanism against pathogens and plays a vital role in maintaining host homeostasis. In recent years, natural polysaccharides have emerged as promising immunomodulators due to
Wenlei Nie, Xuecong Tong, Qiao Ding, Xiaojun Huang   +3 more
wiley   +1 more source

Prognostic factors and treatment outcomes of allogeneic stem cell transplantation in lymphoid malignancy. [PDF]

Blood Res
Kim H, Chung H, Kook HW, Kim SJ, Kim YR, Cho H, Cheong JW.   +6 more
europepmc   +1 more source

Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study. [PDF]

Bone Marrow Transplant
Wilcken H, Kaier K, Meyer T, Waterhouse M, Gräßel L, Duque-Afonso J, Marks R, Wäsch R, Finke J, Zeiser R, Maas-Bauer K, Wehr C.   +11 more
europepmc   +1 more source